Candel Therapeutics said it posted third-quarter 2026 financial results, but the announcement disclosed no revenue, profit or guidance figures. The company rema

BWB News TV • 2026-11-12 22:22 UTC • By Billy Odell Tucker-Robinson

Candel Therapeutics said it posted third-quarter 2026 financial results, but the announcement disclosed no revenue, profit or guidance figures. The company remains focused on oncology, advancing multiple cancer immunotherapy programs.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly